Are female bipolar patients of reproductive age aware of the teratogenic risk of sodium valproate? A qualitative study

Show simple item record

dc.contributor.author Sibanyoni, A.U.D.
dc.contributor.author Joubert, Marinda
dc.contributor.author Naidu, Kalai
dc.date.accessioned 2023-02-22T09:30:27Z
dc.date.available 2023-02-22T09:30:27Z
dc.date.issued 2022-01-31
dc.description A.U.S. was the principal investigator of the project in the context of her master’s in psychiatry. She wrote the research protocol, gathered and analysed the data, interpreted the findings and wrote the final manuscript. M.J. was the supervisor and K.N. the co-supervisor of the master’s study and they assisted with the formulation of the research question, the analysis and interpretation of the data and contributed to the writing of the manuscript. en_US
dc.description.abstract BACKGROUND : Sodium valproate is considered the most teratogenic of all anticonvulsant drugs. Internationally, new regulations require women to sign risk assessment forms if initiated on it. AIM : This study aimed to explore patients’ awareness of the teratogenic risk of sodium valproate. SETTING : Weskoppies Psychiatric Hospital, Tshwane, Gauteng. METHODS : We conducted a qualitative study comprising 23 semi-structured interviews with female bipolar patients of reproductive age at a tertiary psychiatric hospital in South Africa. RESULTS : Patient psychoeducation and self-education is improving as many patients were aware of the risk of teratogenicity of sodium valproate either by being educated or by searching online after developing an interest. Our study identified the need for female patients to be educated about contraceptive use when starting on sodium valproate to avoid pregnancy. CONCLUSION : Our study shows that patients are becoming more aware of the teratogenic risk of sodium valproate. This suggests that consultations focusing on the issues of conception and the use of sodium valproate in women of childbearing potential has improved. en_US
dc.description.department Psychiatry en_US
dc.description.librarian am2023 en_US
dc.description.uri http://www.sajpsychiatry.org en_US
dc.identifier.citation Sibanyoni, A.U., Joubert, M. & Naidu, K. Are female bipolar patients of reproductive age aware of the teratogenic risk of sodium valproate? A qualitative study. South African Journal of Psychiatry 2022;28(0), a1719. https://DOI.org/10.4102/sajpsychiatry.v28i0.1719. en_US
dc.identifier.issn 1608-9685 (print)
dc.identifier.issn 2078-6786 (online)
dc.identifier.other 10.4102/ sajpsychiatry.v28i0.1719
dc.identifier.uri https://repository.up.ac.za/handle/2263/89759
dc.language.iso en en_US
dc.publisher AOSIS en_US
dc.rights © 2022. The Authors. Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License. en_US
dc.subject Sodium valproate (epilim) en_US
dc.subject Teratogenicity en_US
dc.subject Bipolar disorder en_US
dc.subject Childbearing age en_US
dc.title Are female bipolar patients of reproductive age aware of the teratogenic risk of sodium valproate? A qualitative study en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record